Householder Group Estate & Retirement Specialist’s BioMarin Pharmaceuticals BMRN Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3	Closed	–	–	607
2024 Q3	$0	Buy	+3	New	+$251	﹤0.01%	1164
2024 Q2	–	Sell	-3	Closed	-$262	–	1203
2024 Q1	$262	Hold	3	–	–	﹤0.01%	1199
2023 Q4	$0	Hold	3	–	–	﹤0.01%	1141
2023 Q3	$265	Buy	+3	New	+$267	﹤0.01%	1220
2023 Q1	$0	Hold	3	–	–	﹤0.01%	1224
2022 Q4	$0	Hold	3	–	–	﹤0.01%	409
2022 Q3	$0	Buy	+3	New	+$267	﹤0.01%	1091

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's BMRN Position: Q4 2024 in Review

Householder Group Estate & Retirement Specialist sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2024, closing a stake of 3 shares.

Householder Group Estate & Retirement Specialist first reported a position in BMRN in Q3 2022 and held it in 7 quarters. The position peaked at $265 in Q3 2023. 544 funds tracked by Wall St. Rank hold BMRN as of Q4 2024.

Householder Group Estate & Retirement Specialist reported no remaining BioMarin Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Householder Group Estate & Retirement Specialist sold 3 BioMarin Pharmaceuticals shares in Q4 2024.
Householder Group Estate & Retirement Specialist first reported a position in BioMarin Pharmaceuticals in Q3 2022 and held it in 7 quarters.
Householder Group Estate & Retirement Specialist's BioMarin Pharmaceuticals position peaked at $265 in Q3 2023.
544 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2024, filed 15 Jan 2025.